| Identification | Back Directory | [Name]
inulicin | [CAS]
33627-41-7 | [Synonyms]
inulicin
Britannilactone
inulicin USP/EP/BP
Inulicin（1-O-acetyl Britannilactone）
1-O-Acetylbritannilactone (Inulicin)
6-(3-acetoxy-propyl)-4-hydroxy-5,7-dimethyl-3-methylene-3,3a,4,5,8,8a-hexahydro-cyclohepta[b]furan-2-one
(3aS)-3,3aα,4,5,8,8aα-Hexahydro-4α-hydroxy-6-(3-acetoxypropyl)-5α,7-dimethyl-3-methylene-2H-cyclohepta[b]furan-2-one
(3aS)-6-(3-Acetoxypropyl)-3,3aα,4,5,8,8aα-hexahydro-4α-hydroxy-5α,7-dimethyl-3-methylene-2H-cyclohepta[b]furan-2-one
(3aS,4S,7aR)-5-[(1S)-4-(Acetyloxy)-1-methylbutyl]-3a,4,7,7a-tetrahydro-4-hydroxy-6-methyl-3-methylene-2(3H)-benzofuranone
2(3H)-Benzofuranone,5-[(1S)-4-(acetyloxy)-1-methylbutyl]-3a,4,7,7a-tetrahydro-4-hydroxy-6-methyl-3-methylene-,(3aS,4S,7aR)- | [Molecular Formula]
C17H24O5 | [MOL File]
33627-41-7.mol | [Molecular Weight]
308.37 |
| Chemical Properties | Back Directory | [Melting point ]
124.0-126.1 °C | [Boiling point ]
481.7±45.0 °C(Predicted) | [density ]
1.16 | [storage temp. ]
4°C, protect from light | [solubility ]
DMSO: soluble | [form ]
A solid | [pka]
13.71±0.60(Predicted) | [color ]
White to off-white | [biological source]
plant | [InChI]
InChI=1S/C17H24O5/c1-9(6-5-7-21-12(4)18)14-10(2)8-13-15(16(14)19)11(3)17(20)22-13/h9,13,15-16,19H,3,5-8H2,1-2,4H3/t9-,13+,15+,16+/m0/s1 | [InChIKey]
QKUFZFLZBUSEHN-CZLJMHDISA-N | [SMILES]
O1[C@]2([H])CC(C)=C([C@@H](C)CCCOC(C)=O)[C@@H](O)[C@]2([H])C(=C)C1=O |
| Hazard Information | Back Directory | [Uses]
Inulicin is a natural product derived from plant source th at finds application in compound screening libraries, metabolomics, phytochemical, and pharmaceutical research. | [Biological Activity]
Inulicin (1-O-Acetylbritannilactone) is an active compound isolated from Inula Britannica L. It inhibits VEGF-mediated activation of Src and FAK. It also inhibits LPS-induced PGE2 production and COX-2 expression, as well as NF-κB activation and translocation. | [in vivo]
Administration of a single dose of Inulicin (1-O-Acetylbritannilactone; 12 mg/kg/day) remarkably suppresses growth of A549 xenografts in nude mice. In vivo microvessels formation and Src activation are also significantly inhibited in Inulicin-treated xenograft tumors. To investigate the potential activity of Inulicin in vivo, a nude mice xenograft model is applied. | [target]
| [IC 50]
NF-κB; COX-2 | [storage]
4°C, protect from light |
|
|